193 related articles for article (PubMed ID: 16914297)
1. Evaluation of cocktail approach to standardise Caco-2 permeability experiments.
Koljonen M; Hakala KS; Ahtola-Sätilä T; Laitinen L; Kostiainen R; Kotiaho T; Kaukonen AM; Hirvonen J
Eur J Pharm Biopharm; 2006 Nov; 64(3):379-87. PubMed ID: 16914297
[TBL] [Abstract][Full Text] [Related]
2. Development of an on-line extraction turbulent flow chromatography tandem mass spectrometry method for cassette analysis of Caco-2 cell based bi-directional assay samples.
Smalley J; Kadiyala P; Xin B; Balimane P; Olah T
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(2):270-7. PubMed ID: 16307910
[TBL] [Abstract][Full Text] [Related]
3. The impact of protein on Caco-2 permeability of low mass balance compounds for absorption projection and efflux substrate identification.
Liu T; Chang LJ; Uss A; Chu I; Morrison RA; Wang L; Prelusky D; Cheng KC; Li C
J Pharm Biomed Anal; 2010 Apr; 51(5):1069-77. PubMed ID: 20036089
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: in vitro evaluation in intestinal epithelial cells (Caco-2).
Kotzé AF; Thanou MM; Luebetaen HL; de Boer AG; Verhoef JC; Junginger HE
J Pharm Sci; 1999 Feb; 88(2):253-7. PubMed ID: 9950647
[TBL] [Abstract][Full Text] [Related]
5. Caco-2 cells and Biopharmaceutics Classification System (BCS) for prediction of transepithelial transport of xenobiotics (model drug: caffeine).
Smetanova L; Stetinova V; Kholova D; Kvetina J; Smetana J; Svoboda Z
Neuro Endocrinol Lett; 2009; 30 Suppl 1():101-5. PubMed ID: 20027153
[TBL] [Abstract][Full Text] [Related]
6. Parallel artificial membrane permeability assay (PAMPA) combined with a 10-day multiscreen Caco-2 cell culture as a tool for assessing new drug candidates.
Masungi C; Mensch J; Van Dijck A; Borremans C; Willems B; Mackie C; Noppe M; Brewster ME
Pharmazie; 2008 Mar; 63(3):194-9. PubMed ID: 18444507
[TBL] [Abstract][Full Text] [Related]
7. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
[TBL] [Abstract][Full Text] [Related]
8. Drug adsorption to plastic containers and retention of drugs in cultured cells under in vitro conditions.
Palmgrén JJ; Mönkkönen J; Korjamo T; Hassinen A; Auriola S
Eur J Pharm Biopharm; 2006 Nov; 64(3):369-78. PubMed ID: 16905298
[TBL] [Abstract][Full Text] [Related]
9. Effect of experimental pH on the in vitro permeability in intact rabbit intestines and Caco-2 monolayer.
Lee KJ; Johnson N; Castelo J; Sinko PJ; Grass G; Holme K; Lee YH
Eur J Pharm Sci; 2005 Jun; 25(2-3):193-200. PubMed ID: 15911214
[TBL] [Abstract][Full Text] [Related]
10. Validation of the 96 well Caco-2 cell culture model for high throughput permeability assessment of discovery compounds.
Marino AM; Yarde M; Patel H; Chong S; Balimane PV
Int J Pharm; 2005 Jun; 297(1-2):235-41. PubMed ID: 15907606
[TBL] [Abstract][Full Text] [Related]
11. Transport evaluation of salicylic acid and structurally related compounds across Caco-2 cell monolayers and artificial PAMPA membranes.
Koljonen M; Rousu K; Cierny J; Kaukonen AM; Hirvonen J
Eur J Pharm Biopharm; 2008 Oct; 70(2):531-8. PubMed ID: 18582575
[TBL] [Abstract][Full Text] [Related]
12. Transport of parthenolide across human intestinal cells (Caco-2).
Khan SI; Abourashed EA; Khan IA; Walker LA
Planta Med; 2003 Nov; 69(11):1009-12. PubMed ID: 14735438
[TBL] [Abstract][Full Text] [Related]
13. Drug permeability across a phospholipid vesicle based barrier: a novel approach for studying passive diffusion.
Flaten GE; Dhanikula AB; Luthman K; Brandl M
Eur J Pharm Sci; 2006 Jan; 27(1):80-90. PubMed ID: 16246536
[TBL] [Abstract][Full Text] [Related]
14. Caco-2 permeability of weakly basic drugs predicted with the double-sink PAMPA pKa(flux) method.
Avdeef A; Artursson P; Neuhoff S; Lazorova L; Gråsjö J; Tavelin S
Eur J Pharm Sci; 2005 Mar; 24(4):333-49. PubMed ID: 15734300
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Caco-2 cell monolayer drug transport properties by cassette dosing using UV/fluorescence HPLC.
Palmgrén JJ; Mönkkönen J; Jukkola E; Niva S; Auriola S
Eur J Pharm Biopharm; 2004 Mar; 57(2):319-28. PubMed ID: 15018991
[TBL] [Abstract][Full Text] [Related]
16. Use of simulated intestinal fluid for Caco-2 permeability assay of lipophilic drugs.
Fossati L; Dechaume R; Hardillier E; Chevillon D; Prevost C; Bolze S; Maubon N
Int J Pharm; 2008 Aug; 360(1-2):148-55. PubMed ID: 18539418
[TBL] [Abstract][Full Text] [Related]
17. In vitro permeability of eight beta-blockers through Caco-2 monolayers utilizing liquid chromatography/electrospray ionization mass spectrometry.
Caldwell GW; Easlick SM; Gunnet J; Masucci JA; Demarest K
J Mass Spectrom; 1998 Jul; 33(7):607-14. PubMed ID: 9692244
[TBL] [Abstract][Full Text] [Related]
18. The suitability of an in situ perfusion model for permeability determinations: utility for BCS class I biowaiver requests.
Kim JS; Mitchell S; Kijek P; Tsume Y; Hilfinger J; Amidon GL
Mol Pharm; 2006; 3(6):686-94. PubMed ID: 17140256
[TBL] [Abstract][Full Text] [Related]
19. Fluorescein transport properties across artificial lipid membranes, Caco-2 cell monolayers and rat jejunum.
Berginc K; Zakelj S; Levstik L; Ursic D; Kristl A
Eur J Pharm Biopharm; 2007 May; 66(2):281-5. PubMed ID: 17129714
[TBL] [Abstract][Full Text] [Related]
20. Theoretical investigation of passive intestinal membrane permeability using Monte Carlo method to generate drug-like molecule population.
Sugano K
Int J Pharm; 2009 May; 373(1-2):55-61. PubMed ID: 19429288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
